Key result
Initial single-pill combinations in young hypertensive adults are linked to ~12% better medication adherence.
Why the study?
Poor adherence to antihypertensive medication remains a significant barrier to blood pressure control in young patients, prompting an investigation into associated factors.
What factors are associated with good antihypertensive medication adherence in young adults?
Cohort (n=141,132)
What factors are associated with good antihypertensive medication adherence in young adults?
Effect estimate: OR 1.12 (95% CI 1.07-1.18)
In young adults with hypertension, initial use of single-pill combinations, renin-angiotensin blockers, or calcium-channel blockers is associated with significantly better medication adherence compared to diuretics.
May inform initial therapy selection in young adults; leaves open causal effects and outcome benefits.
Background: Poor adherence to antihypertensive medication remains a significant barrier to blood pressure control in young patients. The objective of this study was to identify factors associated with antihypertensive medication adherence among young adults with hypertension. Methods: From the Korean National Health Insurance Service database, we included 141,132 participants aged 20 to 39 years (80.4% male), without cardiovascular disease, who initiated antihypertensive medication between 2013 and 2018. Participants were categorized as exhibiting good adherence (proportion of days covered [PDC] ≥ 0.8) or poor adherence (PDC < 0.8) to antihypertensive medication during the first year of treatment. We investigated the associations of demographic, lifestyle, and clinical factors with good medication adherence based on logistic regression analysis. Results: = 61,107) of young adults with hypertension showed good adherence to antihypertensive medication. Male sex, older age, higher income, urban residence, non-smoking, and higher physical activity were associated with good medication adherence. Initial combination therapy, especially with single-pill combination (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.07-1.18), was associated with good adherence. Among patients under monotherapy, initial use of renin-angiotensin blockers (OR, 5.24; 95% CI, 4.47-6.15) or calcium-channel blockers (OR, 4.07; 95% CI, 3.47-4.78) was associated with better adherence than initial diuretics. Conclusions: Although antihypertensive medication adherence is generally poor among young adults, we identified potential demographic and clinical factors associated with good adherence to antihypertensive treatment. Initial use of a single-pill combination may promote adherence in young patients, and its long-term clinical outcomes warrant further investigation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted a cohort in Hypertension (n=141,132). Single-pill combination therapy vs. No single-pill combination was evaluated on Good medication adherence (proportion of days covered ≥ 0.8) (OR 1.12, 95% CI 1.07-1.18). Among young adults newly treated for hypertension, initial use of a single-pill combination was associated with better medication adherence (OR 1.12) during the first year of treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: